Usually,the poison is in the dose, which is obviously also a factor
Within three to four years, the oral small-molecule sub-class is likely to have at least one or two more approved members, and price competition will start to put pressure on the injectables in cash-pay and lower-income markets
We want you to weigh potential benefits and risks of Wegovy for weight loss, including potential improvements in weight-related health conditions
There are indeed first attempts to use cerebral organoids for exploring the effects of glucocorticoids on early human brain development, mimicking early-life stress exposures [246] as well as the use of human hippocampal progenitor cells to test the effects of specific nutrients [247, 248] and of how fatty acid exposure interacts with glucocorticoids [249] on the neurogenic process
Finally, genetic disorders that impair antioxidant defenses, such as glucose-6-phosphate dehydrogenase (G6PD) deficiency, may modulate susceptibility to ferroptosis in osteogenic cells
Why does an available FDA-approved product or standard treatment not meet my clinical need